compound 28

Compound 28 (mTOR inhibitor WYE-28) is a selective inhibitor of mTOR (IC50=0.08 nM). Also inhibits PI3Kα (IC50 6 nM).

Compound 3289-28-9, with CAS No. 3289-28-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 3289-28-9 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 28281-76-7, with CAS No. 28281-76-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 28281-76-7 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 28226-22-4, with CAS No. 28226-22-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 28226-22-4 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12148, with CAS No. 2840-28-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12148 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12700, with CAS No. 1468-28-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12700 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13647, with CAS No. 445-28-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13647 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13944, with CAS No. 175278-28-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13944 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14044, with CAS No. 2051-28-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14044 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14059, with CAS No. 17766-28-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14059 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14267, with CAS No. 1192-28-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14267 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14332, with CAS No. 643-28-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14332 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14430, with CAS No. 7391-28-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14430 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr16669, with CAS No. 20532-28-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr16669 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0066, with CAS No. 14047-28-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0066 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

sn-Glycero-3-phosphocholine (Choline glycerophosphate) is a natural choline compound found in the brain and in milk. It is also a parasympathomimetic acetylcholine precursor which may have a potential for the treatment of Alzheimer's disease and dementia. sn-Glycero-3-phosphocholine rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of the acetylcholine neurotransmitter. It is a non-prescription drug in most countries due to its Generally Recognised As Safe (GRAS) status [1]. Studies have investigated its efficacy for cognitive disorders including stroke and Alzheimer's disease. An Italian multicentre clinical trial on 2, 044 patients suffering from recent stroke were supplied Glycerylphosphorylcholine in doses of 1, 000 mg/day for 28 days and 400 mg three times per day for the five ensuing months. The trial confirmed the therapeutic role of alpha-GPC on the cognitive recovery of patients based on four measurement scales, three of which reached statistical significance [2].

Compound 791-28-6, with CAS No. 791-28-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 791-28-6 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12287, with CAS No. 64273-28-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12287 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12345, with CAS No. 6314-28-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12345 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12427, with CAS No. 124959-28-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12427 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12448, with CAS No. 3704-28-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12448 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12865, with CAS No. 131986-28-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12865 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13189, with CAS No. 74042-28-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13189 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13409, with CAS No. 23815-28-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13409 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.